Aqilion: "It has been a really busy year"
Summer is just around the corner and it's time for a news update from the biotechnology company Aqilion. CEO Sarah Fredriksson came to...
BioStock Investor Pitch: Chosa Oncology
Biotechnology company Chosa Oncology focuses on precision medicine in cancer treatment....
A visionary outlook on cancer therapy for 2040
This panel on the future of immunooncology has...
Abarceo Pharma | Global Forum 2025
Chairman and CEO Adam Bruce presents Abarceo Pharma...
IRLAB Therapeutics | Global Forum 2025
CEO Kristina Torfgård presents IRLAB Therapeutics at BioStock...
RECOMMENDED
Report commentary, company presentation or capital markets day?
Communicate professionally with the market and nurture your brand!
BioStock's studio meets your needs with technical quality and expertise.
Alligator BioScience | Global Forum 2025
CEO Søren Bregenholt presents Alligator BioScience at BioStock...
Fireside Chat with Steve Smith and Søren Bregenholt
An in-depth conversation of IP and its procedures...
Health & Wealth #19 | Live with Martin Åmark, Xbrane Biopharma | Global Forum 2025
A Health & Wealth podcast episode featuring Martin...
Xbrane Biopharm | Global Forum 2025
CEO Martin Åmark presents Xbrane Biopharma at BioStock...
BioInvent International | Global Forum 2025
CSO Björn Frendéus presents BioInvent International at BioStock...
Simsen Diagnostics | Global Forum 2025
CEO Pontus Rhen presents Simsen Diagnostics at BioStock...
Smart Money in Life Science – Insights from Top Investors
A Panel discussion at BioStock Global Forum featuring...
Health & Wealth #18 | Live with Claus Johansen, Global Health Invest | Global Forum 2025
A Health & Wealth podcast episode featuring Claus...
Cinclus Pharma | Global Forum 2025
CEO Christer Ahlberg presents Cinclus Pharma at BioStock...
Oxcia | Global Forum 2025
CEO Ulrika Warpman Berglund presents Oxcia at BioStock...
Lumito | Global Forum 2025
CEO Sanna Wallenborg presents Lumito at BioStock Global...
China: An Emerging Powerhouse of Global Pharma
A Panel discussion at BioStock Global Forum featuring...
Notes
Alligator Bioscience receives FDA approval for phase III mitazalimab dose
Lena Åredal appointed new CEO of SyntheticMR
BioArctic advances phase IIa study with exidavnemab
Novo Nordisk advances amycretin to Phase III
BioNTech acquires CureVac for $1,25 billion
NEWSLETTER
NEWS
AstraZeneca in billion-dollar deal in AI
Kancera rises on positive results from the KANDOVA study
New success strengthens Alzinova's licensing opportunities for ALZ-101
Upcoming events!
Investing in Life Science
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
Bispecific and Chinese the new black in cancer
The venture capital cycle is complete – we are back where we started
